US 7919513
Inhibitors of p38
granted A61PA61P1/02A61P1/04
Quick answer
US patent 7919513 (Inhibitors of p38) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P1/02, A61P1/04, A61P1/16, A61P1/18